New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 15, 2013
19:17 EDTVRA, CBK, TTMI, FIVE, PCRX, DELL, CRSOn The Fly: After Hours Movers
UP AFTER EARNINGS/GUIDANCE: Vera Bradley (VRA), up 9.7% after raising its Q4, FY12 EPS views... Christopher & Banks (CBK), up 8.4% after raising its Q4 SSS view... TTM Technologies (TTMI), up 6.8% after providing Q4 EPS and revenue guidance within range of Street... DOWN AFTER EARNINGS/GUIDANCE: Five Below (FIVE), down 1.8% despite raising its Q4 guidance... Pacira Pharmaceuticals (PCRX), down 4.6% after providing Q4, FY12 revenue guidance... Carpenter Technology (CRS), down 6% after providing Q2 EPS, revenue guidance below Street estimates... ALSO LOWER: Dell (DELL), down 1.2% after CNBC's David Faber reported a buyout deal for the company would likely be worth $13.50-$14 per share.
News For VRA;CBK;TTMI;FIVE;PCRX;DELL;CRS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
09:14 EDTPCRXOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Visa (V), up 4%... MasterCard (MA), up 2.5%... Alcatel-Lucent (ALU), up 12.5%... TASER (TASR), up 4%... JDSU (JDSU), up 3.8%... Radian Group (RDN), up 9%... DreamWorks Animation (DWA), up 1.7%... Take-Two (TTWO), up 7.7%. ALSO HIGHER: Grand Canyon (LOPE), up 10.5%, upgraded at Piper Jaffray after the company formed a committee to explore conversion to a nonprofit entity... Walter Energy (WLT), up 6.8% after lowering FY14 capital expenditures view, reporting lower than expected losses... Novavax (NVAX), up 7% after getting fast track designation for H7N9 VLP. DOWN AFTER EARNINGS: Glu Mobile (GLUU), down 16.6%... Alliance Fiber Optic (AFOP), down 18.4%... Pacira (PCRX), down 6.4%. ALSO LOWER: Sturm, Ruger (RGR), down 10% following Q3 results, cutting Q3 dividend. Peer gunmaker Smith & Wesson (SWHC) also down 3.7% after Ruger's report... Western Gas Partners (WES), down 4.4% after its 7.5M common units spot secondary priced at $70.85... ACCO Brands (ACCO), down 1.1%, downgraded at KeyBanc following the company's Q3 results... Fiat Chrysler (FCAU), down 1.1% after reported to be recalling over 300K Ram trucks due to fire concern... Inogen (INGN), down 2.3% after 2.1M share secondary offering of common stock priced at $21.50.
06:32 EDTPCRXPacira reports Q3 Exparel net product sales up 12% to $50.2M
Subscribe for More Information
06:31 EDTPCRXPacira reports Q3 non-GAAP EPS 16c, consensus 10c
Subscribe for More Information
October 29, 2014
16:50 EDTTTMITTM Technologies sees Viasystems deal closing in 1H15
Subscribe for More Information
16:49 EDTTTMITTM Technologies sees Q4 EPS 22c-28c, consensus 25c
Sees Q4 revenue $370M-$390M, consensus $380.73M.
16:48 EDTTTMITTM Technologies reports Q3 EPS 13c, consensus 15c
Subscribe for More Information
October 27, 2014
16:03 EDTPCRXPacira EXPAREL use leads to significant reduction in opioid adverse events
Pacira Pharmaceuticals announced results of an independent, physician-initiated study that reinforce the positive impact of an EXPAREL-based pain management regimen on reducing postsurgical complications associated with opioid use. The data, presented at the American College of Surgeons, or ACS, Clinical Congress, found that patients treated with EXPAREL experienced statistically significantly lower rates of urinary retention, respiratory depression and fall risk compared to their counterparts who received the previous standard of care, or SOC. The ACS Clinical Congress is being held October 26-30 at the Moscone Center in San Francisco. The study evaluated 82 patients undergoing open ventral hernia repair or laparoscopic colon resection, all of whom were treated by Dr. Redan. Thirty-seven patients received the SOC: intravenous hydromorphone or morphine with or without epidurals and/or IV acetaminophen. The other 45 patients received infiltration with EXPAREL in addition to the SOC. of EXPAREL resulted in a statistically significant reduction (P<0.001) in the amount of patients classified as being “high-risk” for falls (8.4% in the EXPAREL group vs 16% in the SOC group) and an increase in patients classified as being “low-risk” for falls (48.7% in the EXPAREL vs 37.6% in the SOC group), according to the Morse Fall Scale designed to predict falls, and assess and address risk factors contributing to fall risk.
07:23 EDTPCRXAmerican College of Surgeons holds a conference
Subscribe for More Information
07:15 EDTFIVEFive Below shares look attractive into holiday, says Wells Fargo
Subscribe for More Information
October 24, 2014
11:32 EDTCRSCarpenter Technology sees richer sequential sales mix to begin in Q2
Subscribe for More Information
10:03 EDTCRSOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Align Technology (ALGN) upgraded to Buy from Hold at Jefferies... Brandywine Realty (BDN) upgraded to Buy from Hold at Stifel... Buffalo Wild Wings (BWLD) upgraded to Buy from Hold at Feltl... Carpenter Technology (CRS) upgraded to Overweight from Neutral at JPMorgan... Check Point (CHKP) upgraded to Buy from Hold at Needham... Diamond Offshore (DO) upgraded at ISI Group... Digital Realty (DLR) upgraded to Market Perform from Underperform at Cowen... EQT Corporation (EQT) upgraded to Buy from Neutral at SunTrust... Education Realty (EDR) upgraded to Buy from Hold at MLV & Co.... Gigamon (GIMO) upgraded to Neutral from Underperform at BofA/Merrill... Halliburton (HAL) upgraded to Buy from Neutral at Citigroup... Invacare (IVC) upgraded at KeyBanc... Knight Transportation (KNX) upgraded to Neutral from Underperform at Credit Suisse... Logitech (LOGI) upgraded to Buy from Neutral at UBS... Lorillard (LO) upgraded to Market Perform from Underperform at Cowen... Maxim Integrated (MXIM) upgraded to Buy from Hold at Deutsche Bank... NCR Corp. (NCR) upgraded to Neutral from Sell at Goldman... Nabors Industries (NBR) upgraded to Buy from Hold at Argus... Nucor (NUE) upgraded to Outperform from Underperform at CLSA... Old National Bancorp (ONB) upgraded to Buy from Neutral at DA Davidson... Plexus (PLXS) upgraded to Outperform from Market Perform at Raymond James... Potash (POT) upgraded to Buy from Hold at TD Securities... Reliance Steel (RS) upgraded to Buy from Hold at Jefferies... ResMed (RMD) upgraded to Outperform from Market Perform at William Blair... Royal Dutch Shell (RDS.A) upgraded to Buy from Neutral at UBS... Swift Transport (SWFT) upgraded to Buy from Hold at Stifel... Vulcan Materials (VMC) upgraded to Overweight from Equal Weight at Stephens... Weatherford (WFT) upgraded to Buy from Neutral at Citigroup.
07:29 EDTCRSCarpenter Technology upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded Carpenter Technology to Overweight following the company's Q1 results on expectations earnings growth will improve from a rebound in aerospace volumes and better margins. The firm keeps a $60 price target for shares.
October 23, 2014
07:13 EDTCRSCarpenter Technology announces $500M share repurchase program
Subscribe for More Information
07:09 EDTCRSCarpenter Technology reports Q1 EPS 25c, consensus 16c
Reports Q1 net sales excluding surcharge $440.1M, consensus $477.46M. Reports Q1 net sales $549.8M.
October 20, 2014
14:22 EDTFIVEFive Below management to meet with BB&T
Meeting to be held in Philadelphia on October 23 hosted by BB&T.
13:10 EDTVRASteve Madden tumbles after providing preliminary Q3 results, FY14 outlook
Shares of shoe and accessory company Steve Madden (SHOO) are tumbling after the company announced preliminary third quarter results that were below analysts' consensus along with a reduction to its fiscal year 2014 outlook. WHAT'S NEW: Steve Madden announced that it is anticipating Q3 earnings per share to be approximately 61c-62c and net sales of $392M, below analysts' consensus estimates of 67c and $415.72M, respectively. The company noted that retail comparable store sales for the quarter are anticipated to be down 7.4%. Steve Madden also reduced its FY14 EPS outlook to $1.81-$1.86 from $2.00-$2.10, well below analysts' $2.02 consensus. The company lowered its net sales projection for the year, and now sees net sales up 1%-2% over fiscal year 2013 versus its previous net sales guidance for up 2%-4% over FY13. The new guidance factors in the recent acquisition of Dolce Vita and current expectations for remainder of the year. On August 14, Steve madden acquired Dolce Vita for $60.3M in cash and previously said the deal would be accretive to earnings in FY14 by 2c-3c and be "modestly accretive" in FY15. WHAT'S NOTABLE: Steve Madden's Chief Executive Officer Edward Rosenfeld said that the company's Q3 earnings were "disappointing" and were the result of weaker than expected retail segment performance. He believes that retail trends in the footwear space will continue to be difficult through the fourth quarter due to a lack of noteworthy fashion trends in the industry. The CEO said that the company's full-year guidance results from this pattern, along with a lowered reorder outlook in its wholesale segment. Rosenfeld is still confident, however, in the company's business model and believes that its acquisitions of Dolce Vita and its Mexican licensee will fuel the business forward over the long term. OTHERS TO WATCH: Competitors of Steve Madden include Michael Kors (KORS), Coach (COH), Kate Spade (KATE), and Vera Bradley. PRICE ACTION: During afternoon trading, shares of Steve Madden fell $2.62 or 8.2%, to $29.32. Over the last twelve months, the stock has fallen over 15%.
07:12 EDTPCRXCongress of Neurological Surgeons to hold annual meeting
Subscribe for More Information
October 17, 2014
10:00 EDTFIVEOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:11 EDTFIVEFive Below initiated with a Hold at Stifel
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use